Safety and Preliminary Efficacy of Sintilimab Plus P-Gemox (Pegaspargase, Gemcitabine and Oxaliplatin) Regimen As First-Line Treatment for Patients with Advanced Extranodal Natural Killer/T Cell Lymphoma, Nasal Type: An Open-Label, Multicenter, Phase 2 Study

Authors :: Cai, Qingqing
Huang, Huiqiang
Liu, Panpan
Zhou, Hui
Li, Yajun
Zhang, Yujing
Lu, Lixia
Gao, Yan
Zhang, Xuanye
Xia, Yi
Cai, Jun
Su, Ning
Ma, Shuyun
Yang, Hang
Fang, Yu
Source :: Blood; November 2020, Vol. 136 Issue: Supplement 1 p26-27, 2p
Publication Year :: 2020
Abstract: No relevant conflicts of interest to declare.Sintilimab is medication that is indicated for the treatment of relapsed or refractory classical Hodgkin's lymphoma after failure of at least second-line systemic chemotherapy.

Full Text Access

Tools